We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
SIGA Technologies
SIGA
$219M
| $395K | ﹤0.01% |
53,500
+361
| +0.7% | +$2.31K |
|
|
RPT
2652
Rithm Property Trust
RPT
$93.7M
| $394K | ﹤0.01% |
4,863
+39
| +0.8% | +$3.13K |
|
|
BLFY
2653
DELISTED
Blue Foundry Bancorp
BLFY
| $393K | ﹤0.01% |
+28,476
| New | +$382K |
|
2654
MetroCity Bankshares
MCBS
$1.03B
| $393K | ﹤0.01% |
18,752
-252
| -1% | -$5K |
|
2655
UWM Holdings
UWMC
$434M
| $393K | ﹤0.01% |
56,514
+21,470
| +61% | +$160K |
|
|
LONA
2656
LeonaBio Inc
LONA
$72.1M
| $392K | ﹤0.01% |
4,176
+150
| +4% | +$15.3K |
|
|
TCS
2657
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $392K | ﹤0.01% |
2,743
+68
| +3% | +$11.4K |
|
2658
Forestar Group
FOR
$1.51B
| $391K | ﹤0.01% |
20,990
+430
| +2% | +$8.68K |
|
|
BDSI
2659
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $391K | ﹤0.01% |
108,348
+1,370
| +1% | +$5.17K |
|
|
VLDR
2660
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $390K | ﹤0.01% |
65,880
+3,425
| +5% | +$25.8K |
|
2661
Allient
ALNT
$1.92B
| $389K | ﹤0.01% |
12,450
+128
| +1% | +$4.19K |
|
2662
Century Casinos
CNTY
$34M
| $389K | ﹤0.01% |
28,844
+1,275
| +5% | +$16.2K |
|
|
AKTS
2663
DELISTED
Akoustis Technologies Inc
AKTS
| $389K | ﹤0.01% |
40,133
+1,992
| +5% | +$19.1K |
|
2664
Arbutus Biopharma
ABUS
$915M
| $388K | ﹤0.01% |
90,464
+2,546
| +3% | +$8.48K |
|
2665
Centrus Energy
LEU
$3.82B
| $388K | ﹤0.01% |
10,043
+996
| +11% | +$27.6K |
|
|
CBAY
2666
DELISTED
Cymabay Therapeutics
CBAY
| $388K | ﹤0.01% |
106,187
+2,086
| +2% | +$8.22K |
|
|
SQZ
2667
DELISTED
SQZ Biotechnologies Company
SQZ
| $388K | ﹤0.01% |
26,886
+1,050
| +4% | +$14.2K |
|
2668
Northrim BanCorp
NRIM
$587M
| $384K | ﹤0.01% |
36,108
+764
| +2% | +$7.88K |
|
2669
Pliant Therapeutics
PLRX
$65M
| $384K | ﹤0.01% |
22,760
+995
| +5% | +$21.1K |
|
|
HBMD
2670
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $383K | ﹤0.01% |
18,875
-36
| -0.2% | -$689 |
|
2671
Aldeyra Therapeutics
ALDX
$93.5M
| $382K | ﹤0.01% |
43,453
+1,923
| +5% | +$17.6K |
|
|
ESPR
2672
DELISTED
Esperion Therapeutics
ESPR
| $381K | ﹤0.01% |
31,612
-1,266
| -4% | -$18.4K |
|
|
MCW
2673
DELISTED
Mister Car Wash
MCW
| $381K | ﹤0.01% |
+20,876
| New | +$414K |
|
2674
Aviat Networks
AVNW
$273M
| $380K | ﹤0.01% |
11,550
+277
| +2% | +$9.57K |
|
|
TACO
2675
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $377K | ﹤0.01% |
43,226
-427
| -1% | -$3.78K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.